In short
The episode “The dawn of the designer baby” (Today in Focus) examines Cathy Tai, a biotech entrepreneur who calls herself a “biotech Barbie,” and her push for germline gene editing to prevent inherited diseases. Host Helen Pidd interviews Guardian features writer Jenny Kleeman, who reports on Tai after attending Tai’s invite-only Carnegie Hall 30th birthday event in Manhattan. Kleeman outlines Tai’s background: Chinese family, moved to Canada, early science-fair success, a “schoolchildren” paper before 16, dropped out of university at 18 via a Peter Thiel Fellowship, and multiple startups.
Key claims
germline editing (CRISPR on eggs/early embryos) could prevent diseases like sickle cell anemia and Huntington’s, but carries safety risks (e.g., mosaicism) and could enable “designer” traits.
Notable examples
Tai’s earlier “Los Angeles Project” (glow-in-the-dark bunnies, “unicorn” horses); her relationship with He Jiankui, who created HIV-edited twins Lulu and Nana and was jailed for illegal embryo editing; investors like Sam Altman and Preventive. Kleeman questions Tai’s transparency (funding/staff withheld), her cost estimates, and the ethics of defining “severe” by parents rather than regulators.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOCathy Tai's Birthday and Background
0:09 to 3:23
Jenny Kleeman shares her experience attending Cathy Tai's extravagant birthday party and introduces her background.
“On a Friday night in April, I was in Manhattan in New York City in Carnegie Hall at a very exclusive event, invite only.”
Cathy Tai's Ambitious Journey
3:23 to 6:10
Discussion on Cathy Tai's early achievements and her controversial relationship with He Jiankui.
“Today in Focus, baby hacking and the biological arms race.”
Cathy's Latest Ventures in Gene Editing
6:10 to 8:40
Exploration of Cathy's current projects in gene editing, including her company Origin Genomics.
“Well, I have to say that since the beginning of 2025, it's been quite a ride for Cathy Tai.”
The Future of Gene Editing
8:40 to 11:12
Discussion on the potential and ethical concerns surrounding gene editing technologies.
“Because all the listeners might remember Dolly the sheep.”
Cathy's Controversial Past Projects
11:12 to 14:00
Jenny reveals Cathy's previous projects, including bioengineering pets and their implications.
“Well, some of the most wealthy people in the world are pouring their money into this kind of research.”
The Ethics of Genetic Engineering in Pets
14:00 to 16:46
Explore the controversial project of bioengineering pets and the implications of animal consent.
“I mean, it wasn't the kind of response you'd expect from someone who's saying, hey, I'm an open book.”
The Rise of He Jiankui and Gene Editing
16:46 to 19:06
Learn about He Jiankui's controversial experiment with gene-edited babies and its implications on ethics and science.
“their marriage didn't survive was because they couldn't be together for logistical reasons.”
Cathy's Approach to Gene Therapy
19:06 to 21:08
Discover how Cathy's gene editing focuses on monogenic diseases and differs from previous methods.
“Yeah, I mean, he was, you know, really experimenting with human life, suturing together different bits of genetic code and hoping for the best.”
The Cost and Ethical Dilemmas of Gene Editing
21:08 to 25:39
Examine the costs associated with gene therapy and the ethical concerns regarding parental choice in genetic modifications.
“I wrote a book, one of the chapters looked at the most expensive medicine in the world, which is a gene therapy for spinal muscular atrophy, where it was at the time that I wrote it.”
The Future of Genetic Enhancement Technology
25:39 to 28:07
Consider the potential future of genetic enhancements and the complexities of genetic traits in humans.
“decide what is serious enough to use this technology?”
Show all 12 chapters
The Inevitability of Genetic Engineering
28:07 to 29:52
Explore the inevitability and ethical implications of genetic engineering and designer babies.
“It's limited only by our understanding of how the genetic code that we have in our cells ends up being expressed in our bodies.”
The Global Race in Genetic Editing
29:52 to 31:31
Discuss the global race in genetic editing and the pressure to innovate without proper regulations.
“And so I do feel like we are moving closer to a world where gene editing of embryos is going to happen.”
Transcript
Automatic transcript. May contain errors.0:00Cathy Tie:This is The Guardian.
0:08Cathy Tie:Today, the biotech Barbie and her mission to produce better, healthier babies.
0:29Jenny Kleeman:On a Friday night in April, I was in Manhattan in New York City in Carnegie Hall at a very exclusive event, invite only.
0:41Cathy Tie:Jenny Kleeman, a features writer for The Guardian was in the Big Apple for a birthday party and the birthday girl, Kathy Tai was providing the entertainment herself in fact, she'd even hired out the venue for the occasion
0:57Jenny Kleeman:She was wearing this pink shimmering gown with a cape on it it was a Jenny Packham gown I looked it up, it costs about£4 ,000 playing this Steinway grand piano on stage at Carnegie Hall, backed by an orchestra. She was playing this Sasson's piece. She was playing it very beautifully, but slightly mechanically and very seriously.
1:30Jenny Kleeman:And then she stood up and bowed. Then everyone in the orchestra and all of us sang Happy Birthday. It was a bit awkward and a bit weird, and we all went upstairs to have a champagne reception on one of the upper floors. And when I was at this champagne reception, I started talking to people, and almost everybody I spoke to had never met Cathy, or had only just met Cathy.
1:55Cathy Tie:Jenny doesn't usually go to strangers' birthday parties halfway across the world, but she's wanted to interview Cathy Tai for a really long time. Because Cathy isn't just any 30-year-old. She is the self-described biotech Barbie. A serial entrepreneur who wants to edit human embryos to make healthier babies. What we're deciding is whether our species will use the most precise biological tool ever developed to prevent suffering, or whether we will let fear, dressed up as caution, make that decision for us.
2:37Cathy Tie:But gene editing could also create designer babies, taller babies, cleverer babies, babies with lighter skin. The technology has the power to alter the trajectory of human evolution forever. And when things go wrong, the consequences could scarcely be more serious. Germline editing has very serious safety concerns that could have irreversible consequences.
3:02Jenny Kleeman:We simply lack the tools to... We're living in this world of hyper-optimisation. We're all supposed to be hacking ourselves, and now we're hacking our babies too. I think the dial has shifted on what we are prepared to do to optimise our offspring, or what some people are prepared to do.
3:20Cathy Tie:From The Guardian, I'm Helen Pidd. Today in Focus, baby hacking and the biological arms race.
3:31Cathy Tie:Jenny, welcome back to Today in Focus. Great to see you.
3:34Jenny Kleeman:very lovely to be back here.
3:35Cathy Tie:So you're back in London after what sounds like an incredibly glamorous trip to New York to celebrate Cathy Tye's 30th birthday. And I don't remember playing a grand piano in concert to celebrate my 30th. I think I was in some dodgy pub in Hackney for mine. What's her backstory? How has she got to this position? What qualifications has she gotten? And how can she already afford to hire out the Carnegie Hall for her 30th birthday?
3:58Jenny Kleeman:she comes from a Chinese family uh she wouldn't tell me exactly where she was born she said it was just outside of Beijing her family moved to Canada when she was very young four or five and from what I can tell she was a really really good student she's clearly brilliant at the piano very very academic was winning vast amounts of money in science fairs as a teenager she had her first scientific paper published when she was 16. She likes to say that a lot. And in previous reporting about her, it always says, oh, she had her first scientific paper published before she was 16. But I actually looked up what paper this was, and it's in a journal for schoolchildren.
4:38Jenny Kleeman:So while she did have a scientific paper published, there's a bit of spin there. And that's something you need to bear in mind all the time with Cathy Tai. There's always a bit of spin. She got in trouble once for missing a biology class because she was preparing for one of these fairs where she'd win lots of money and her teacher was angry with her for missing the class. And she asked a teacher, well, what scientific papers have you published? I've had a paper published. She went to university when she was very young and she dropped out at age 18 because she won a fellowship offered by the very famous billionaire Peter Thiel.
5:12Jenny Kleeman:It's a Thiel Fellowship. At the time, it was a$100 ,000 fellowship. Now it's a quarter of a million dollars. He gives these fellowships to people aged under 22 who agree to drop out of university and build something. And it comes from this, I guess it's an idea that smart people are wasting their time at university. They could do better if they went into the real world. And she says from speaking to her, that was clearly the formative experience for her. And it's given her this very, she says, useful irreverence, this sense of not wanting to go along with the orthodoxy challenging things. She was on Forbes's list of 30 most interesting individuals under 30 when she was 22.
5:54Jenny Kleeman:She set up lots of companies. And so, yes, she is, as she calls herself, a serial entrepreneur and proud of it.
6:03Cathy Tie:Okay, so she is clearly a very bright spark. She's very ambitious. But nothing demonstrates the level of her ambition, I think, than the last 18 months, does it?
6:14Jenny Kleeman:Well, I have to say that since the beginning of 2025, it's been quite a ride for Cathy Tai.
6:20Cathy Tie:So how did I end up here? Why am I in this wonderful suite, but in New York City with no home, traveling from city to city? What am I doing here? How did I end up here? Record snatch, freeze frame. How did I end up in this situation?
6:33Jenny Kleeman:She started it by announcing her first ever biotech startup, which was a company that sought to genetically engineer exotic pets for wealthy pet owners. And then she moved to Beijing, or at least she tried to move to Beijing because she fell in love with He Zhang Kui, who is probably one of the most notorious scientists in the world. So a Chinese scientist helped create the world's first genetically edited babies. He is going to jail. His name is He Jianhui of China. He is going to be in prison for three years for carrying out what the Chinese government says were illegal medical practices. And following his release from prison, she was communicating with him.
7:17Jenny Kleeman:She met him, fell in love with him, tried to move to Beijing to be with him. But when she was on her layover in Manila, she was informed that the Chinese authorities would not be allowing her into Beijing. So she spent a while in limbo trying to work out what was going on. Eventually, she moved back to Toronto, which is where she's originally from. She's from Canada. Her marriage to He Jun Kuei dissolved. They were separated.
7:44Cathy Tie:Later on, we're going to talk more about this short-lived husband and why his work was so controversial. but spoiler alert, it involves some real-life human twins. But can you first tell us about Cathy's latest company, Origin Genomics?
7:58Jenny Kleeman:Cathy Tai wants to use germline gene editing to stop serious diseases, genetically inherited diseases. And what germline gene editing is, is it's basically editing the genes of eggs or very, very early stage embryos. and you use a gene editing tool called CRISPR to go in and change genes. And she says that if you change the genes of the very earliest forms of human life, then those changes will be replicated in all the cells as they divide and reproduce. And you can essentially prevent really serious diseases like sickle cell anemia, like Huntington's diseases, diseases that cause a lot of suffering.
8:39Cathy Tie:Just how new is this technology really? Because all the listeners might remember Dolly the sheep. Dolly the cloned sheep. I think she came into the world in the lab in 1996. And there is already embryo screening, isn't there, for exactly the sort of diseases, these hereditary diseases that you've just listed.
8:57Jenny Kleeman:Yeah, I mean, this is a very specific technology. This is not cloning. This is not screening. So what happens with screening is you see if the genes are there. What happens with cloning is that you replicate the genes that are there. Gene editing involves changing, deleting, or modifying the genes that are there. And that's been around for about 15 years. This technology has been possible. And for what I understand, that it's not actually difficult to do. The problem is the tools have made mistakes in the past and they've caused, it's called mosaicism. They've caused unintended changes, consequences, genetic changes that aren't quite what's intended.
9:35Jenny Kleeman:But apparently the newest generation of these tools can be quite precise. So it's quite a new field, relatively speaking, and it hasn't, well, we know that it's only been used to our knowledge once before, and that was in human beings, and that was with Hezhen Kwe. Because at the moment, the rules are you're not allowed to use gene editing on an embryo, a human embryo, older than 14 days of gestation, or one that has a chance of one day being implanted and being born as a human being.
10:05Cathy Tie:Okay, so in labs around the world, there are plenty of molecular biologists out there who are experimenting on these very, very young embryos, but nobody's been allowed to actually take it to its, I was going to say natural conclusion. Maybe it's not a natural conclusion of a baby, apart from, as you've already told us, Cathy's short-lived husband.
10:29Jenny Kleeman:Yes, experiments are going on all the time. They're also going on quite a lot with animals. All over the world, these experiments are happening, although actually they're not so much happening in universities. In America, there is a moratorium on doing this research in universities. And this is Cathy's argument, because universities can't get funding to do this research. It's only private companies that can do it. So she's saying that she's flying the flag for science by having a private company that is doing this research that has the potential to transform the lives of people who are the carriers of these very serious, genetic diseases.
11:04Cathy Tie:I mean, clearly the potential is enormous. And has that been recognised by venture capital companies? Is there a lot of money being poured into this kind of research?
11:12Jenny Kleeman:Well, some of the most wealthy people in the world are pouring their money into this kind of research. Sam Altman, the CEO of OpenAI, who owned ChatGPT, and his husband, they have invested in a company called Preventive, which is another gene editing startup that seeks to prevent the same sorts of diseases that Cathy is seeking to prevent. The CEO of Coinbase is also an investor in Preventive and he's spoken quite openly, this guy called Brian Armstrong, about what might be possible in the future. He calls it a Gattaca stack. Gattaca is this famous movie from the 90s with Ethan Hawke in it about a kind of dystopian future where people are genetically engineered.
11:52Jenny Kleeman:He says in the future, people will have babies using embryo selection, gene editing, artificial wombs, various other technologies that we'll be using to make our families.
12:03Cathy Tie:Right, okay. So Kathy's far from the only person trying to make this a reality. So is her biggest challenge then convincing the regulators that this is ethical and that it isn't going to lead to horrendous consequences, that you don't have to be a genetic expert to be able to imagine?
12:21Jenny Kleeman:Yes. Kathy is on a mission to make gene editing acceptable. And I think that's part of the reason why she invited me to her birthday party is she knows that she needs to at least be seen to be being open and transparent, open with the public, engaging with ethicists and in public debates and in a constant dialogue with regulators. And that's her biggest challenge at the moment is to get these norms changed and to get research board approval for the work that she's doing.
13:03Cathy Tie:So you went to meet Cathy. It sounds like it wasn't hard to persuade her to open up to you. If she's on a PR mission to try to persuade people that this isn't as dangerous as it sounds.
13:13Jenny Kleeman:I think it was quite difficult to get her to say anything at all, because I think what she wanted was the publicity, but she didn't want to answer difficult questions. And there were a lot of difficult questions that I wanted to put to her.
13:23Cathy Tie:She invited the wrong journalist then, didn't she?
13:25Jenny Kleeman:I think so. I think so. And she looked genuinely uncomfortable during a lot of our conversation, particularly when I asked her about her marriage to He Jun Kuei. But there were other questions that she should have been more comfortable answering. When you go and interview people, you expect them to be able to answer basic questions. How many people work for you? Who funds you? And she kept saying, well, I'm not at liberty to discuss that at the moment. Our funders are extremely motivated. I've got pioneers working for me, but I'm unfortunately unable to name any of them at the moment, which doesn't really strike me as being very transparent.
14:03Jenny Kleeman:I mean, it wasn't the kind of response you'd expect from someone who's saying, hey, I'm an open book.
14:08Cathy Tie:Yeah. And you piqued my interest when you said that one of her earlier ventures was genetically modifying animals. Tell me about that.
Read the full transcript
14:16Jenny Kleeman:She had a company called the Los Angeles Project, which sought to biohack pets. So making glow-in-the-dark bunnies.
14:25Cathy Tie:Why would you want a glow-in-the-dark bunny so you didn't lose them in the dark?
14:28Jenny Kleeman:Well, I guess if you're a Los Angeles pet owner who has everything, why not have a glow-in-the-dark phosphorescent bunny? Phosphorescent bunny rabbits. She said she was interested in using genetic engineering to turn horses into unicorns, get them to grow own nice big horn. Also other things, slightly more practical, hypoallergenic cats. It sounded like a fun project. I don't know how far she got with it because when I asked her, she wouldn't tell me. She clearly thought it was a lot of fun. She said it was a useful way of understanding genetic engineering, which is what she'd always wanted to do.
15:08Jenny Kleeman:And then I thought, oh yeah, obviously you would try this out on animals first because there aren't the restrictions on animals that there are on human beings. And when I asked her this, when I put that to her, she said, I'm not familiar with what the animal consent process is. And I said, surely there is no animal consent process because animals can't consent to being experimented on. And then she said, yes, I'd rather we didn't talk about this. I don't remember exactly what was going on with that company.
15:34Cathy Tie:Yeah. And after that project, what did she do next? She went to China.
15:39Jenny Kleeman:That's where she met up with Hezhen Kwe, who she had interviewed before. There's a very strange video on Cathy's YouTube channel of her interviewing him.
15:46Cathy Tie:That's great. Thank you. Yeah, just, you know, informally, as an individual outside of science, what do you like to do in your free time? What are your hobbies and what are you passionate about? Well, I love playing golf. I also enjoy...
16:04Jenny Kleeman:She got together with him. I think he told her he was in love with her and it was a bit of a surprise for her. but then she fell in love with him. They got married. She told me they weren't legally married, but there was certainly a wedding. There were wedding photographs all over both of their social media. They had matching wedding bands, custom made that were DNA double helixes. Of course. Of course. She was living in Los Angeles at the time. She went back to the US to pack up all of her stuff. Everything was in storage. Everything was going to be shipped over to Beijing. But then the Chinese government got in the way.
16:38Jenny Kleeman:And she was visibly squirming when I was asking her about him. She looked so uncomfortable. She was going red in the face. I asked her if the only reason why their marriage didn't survive was because they couldn't be together for logistical reasons. And she said yes. So I think if she could have moved to China, she would have. She was really in admiration of him. She saw him as a heretic, you know, someone who is a Teal fellow who has been incubated in a culture of, you know, healthy disrespect for authorities, great for science, is great for the world. Someone like him who would break the rules and create the world's first gene edited babies.
17:17Jenny Kleeman:It sounds very appealing. But when you know the details of what he actually did, and I think most people don't know and don't ask many questions, he's actually a very, very dubious figure. Okay.
17:29Cathy Tie:And can you actually just break down for us exactly what he did?
17:32Jenny Kleeman:This all came to light in 2018 when he gave a presentation about his experiment and he called it an experiment, which was the creation of twin girls, Lulu and Nana, who will be, I think, around nine years old now. So Lulu and Nana's father was HIV positive. And what He Jun Kuei did was he tried to introduce what is a naturally occurring genetic mutation that gives people natural immunity to HIV. This protein is responsible for lots of other stuff as well, not just immunity to HIV. We don't know what the consequences of that would be. So he tried to do this in these two embryos, and he failed. According to his own data, he failed.
18:18Jenny Kleeman:So he caused unknown changes in both of the embryos and he knew this. And yet he still allowed both embryos to be implanted into Lulu and Nana's mother and for Lulu and Nana to be born. What most people understand is he gave these twins immunity to HIV, but he didn't. And also this was not a disease like Huntington's. they weren't carriers of a genetic abnormality that needed to be created he was giving them or trying to give them um a protection against a disease that they might contract because they were living sharing a household with someone who is hiv positive so this is not a necessary life-saving procedure by any stretch of the imagination you can see why he was nicknamed
19:08Cathy Tie:China's Dr Frankenstein, can't you?
19:10Jenny Kleeman:Yeah, I mean, he was, you know, really experimenting with human life, suturing together different bits of genetic code and hoping for the best. Even when he knew that what he had tried to do had failed, he still wanted to see the outcome. And nobody knows what's happened to them. There's a lot of secrecy about it. He hasn't published any information. The Chinese government doesn't want people to know. So the fate of Lulu and Nana is a complete mystery.
19:47Cathy Tie:In terms of what Cathy is wanting to do with her new venture, how does it differ from what her ex-husband, estranged husband was doing?
19:57Jenny Kleeman:Cathy is seeking to target monogenic conditions, so conditions where there is one gene that you can target and change. and for those changes to be made very early on so that the growing embryo does not have this condition and the baby doesn't have it. And that's different from what Hezhenkwe was doing. But there are other ways of achieving the same ends. We can do embryo selection where we screen embryos created in IVF to see which embryos are the carriers of a genetic condition and implant only the ones that aren't the carriers of a condition. Or we can do gene therapy where you deliver a therapy after a person's born.
20:37Jenny Kleeman:And the difference between gene therapy and germline gene correction, which is what Kathy wants to do, when you do gene editing of sperm or of embryos, the changes you make are present in all the cells of the body, including the reproductive cells. So it means that that person and all that person's descendants will have the changes that you make. Gene therapies are very expensive. You have to have a procedure where the medicine is delivered to you. And sometimes that can be painful and sometimes it can take a long time, but not always. I wrote a book, one of the chapters looked at the most expensive medicine in the world, which is a gene therapy for spinal muscular atrophy, where it was at the time that I wrote it.
21:19Jenny Kleeman:And spinal muscular atrophy used to be the most common genetic cause of disease for children under two. So it's quite a common disease. And I know that SMA, the gene therapy for SMA, which is called Zolgensma. It costs$2 million a dose, but it is delivered within a few hours. We were having this conversation and Kathy was saying that gene therapy is really bad. It's really expensive and you have to have chemotherapy. She was talking about this gene therapy for sickle cell. And I said, well, not all gene therapies are like this. For example, Zolgensma, it only takes a few hours to deliver. And she said to me, I'm not familiar with that treatment.
21:58Jenny Kleeman:And the idea of somebody who is specialising in this area not knowing about SMA, which is an incredibly common disease, and not knowing about Zolgensma, which made headlines around the world, is quite astonishing. So she is either very poorly informed or she's not telling the truth when she says that. It's in her interest to spin this idea that all existing treatments are really flawed and that the only real answer to stopping children from suffering is to edit the genes of embryos. Has Kathy got a sense of how much her treatment is going to cost? She has no idea how much it will cost. I heard her on a podcast saying that it would cost about $20 ,000, which is the same price as IVF in the US.
22:39Jenny Kleeman:I put this to her and she basically told me she just made that up on the spot in that podcast. Nonetheless, I know that in America, people are prepared to spend a lot of money on reproductive technology. One of the things that I have found, as somebody who's reported a lot on reproductive technology over the past few years, is the normalisation of pre-implantation genetic testing for things like height, for things like not just gender, but things like intelligence. In America, it's perfectly allowed for you to have your embryos screened and tested so that you implant the ones that are most likely to be healthy and tall or have a particular eye colour.
23:21Jenny Kleeman:That is legal, that is normal, but it's also very expensive. It's seen as a sort of enhanced form of IVF. It's increasingly an option for wealthy Americans.
23:31Cathy Tie:I'm listening to this as somebody who has undergone IVF, which is essentially what any couples who are wanting to do this would have to go through. and when you have a round of IVF every single egg every embryo is so precious I didn't have any kind of pre-genetic screening I didn't need to but the thought of having to discard these precious embryos I think would have been very painful so is that I mean is that one of the advantages that Cathy is selling?
23:58Jenny Kleeman:Absolutely I mean Cathy's big thing is that pre-implantation genetic testing involves throwing out the embryos that do carry the genes that you're seeking not to have in the next generation. And some people don't produce enough embryos. And for some people, every embryo will be affected. Each one of those embryos is incredibly precious. And this gives every embryo a chance. It's an extremely emotive, very powerful and legitimate argument for this. when I went to this Harvard debate where she was speaking at, there were people in the audience who are carriers of diseases where all of their offspring will have this condition.
24:42Jenny Kleeman:So it's a choice between being a parent or not being a parent, this technology.
24:46Cathy Tie:Families should have the choice. It's about the choice of having the option to correct the genome of their children. And if that's something they want to get rid of in their family, they should have the option to do something. No one's coercing them. But taking that option away when the technology could be ready for them. I think that is a form of coercion on its own, and it's pretty unethical.
25:07Jenny Kleeman:Cathy is insistent that she is, at the moment, only looking to stop severe monogenic diseases. So that means things that are dictated by one gene. And things like intelligence and height are polygenic. There's many different genes that come into play there. So she says the technology is too difficult for that. The thing that really fascinates me, though, is if she says she's only looking to stop severe monogenic diseases, she thinks the word severe should be defined by parents, not doctors, because she says, why should doctors and ethicists get to decide what is serious enough to use this technology?
25:49Jenny Kleeman:And you can imagine, not now, but in a time in the future, let's say that you have gene editing to be used to correct Huntington's disease or sickle cell anemia, that you could have down the line people saying, well, I don't want my kids to have osteoporosis. I want them to have stronger bones, or I don't want my kids to have heart disease. I don't want them to have high cholesterol. And, you know, that that could be classed as severe. And what about a world in which, you know, the genetic lottery of not being an intelligent person in an increasingly high stakes competitive world, that could be seen as a really unfair defect.
26:22Jenny Kleeman:If severity of a condition is defined by the parents, you know, you could take that almost anywhere.
26:30Cathy Tie:Yeah. And how does Cathy defend herself and her method against these criticisms, the ethics, this argument that it's a slippery slope?
26:38Jenny Kleeman:She says it's not her problem. She says it's up to regulators and governments to decide where to stop, where to put the guardrails. Her job is to show that the science is safe and efficacious, and that's what she's trying to do. But the rest of it, it's up to democratically elected governments to decide where to draw the line, not her.
27:03Coming up, is it only a matter of time
27:05Cathy Tie:before these genetically edited babies enrol at a nursery near you?
27:25And how far do you think that this enhancement technology could go?
27:30Jenny Kleeman:It's limited only by our understanding of genetics. And I think maybe 20, 30 years ago, we thought, oh, we'll find a gene for this, a gene for that. And we'll be able to, you know, work out what the gene for curly hair is or, you know, and we'd just be able to tweak this and tweak that and change it. And we're learning now that there is a big interplay between different kinds of genes and there is epigenetics where you have a gene, but it's not expressed in the same way. Things are slightly more complicated. But ultimately, if we understand which genes are responsible for which traits down the line, anything might be possible.
28:07Jenny Kleeman:It's limited only by our understanding of how the genetic code that we have in our cells ends up being expressed in our bodies.
28:15Cathy Tie:And you said that she kept on saying that this technology is inevitable. Is it, do you think?
28:23Jenny Kleeman:It's as inevitable as we allow it to be. She said to use the word inevitable 12 times during our conversation in her office. I feel like there is a tide that is turning in the US, having seen the tone and the mood of this debate with this ethicist, having walked around New York and seen the advertising for pre-implantation genetic testing with a slogan for this company is have your best baby this idea that you know just a healthy baby not just a healthy your best baby and i've looked at a lot of technologies where the argument for it is we're helping children do you want little children to suffer and there are very few people who will say yes of course We're happy for little children to suffer in order to maintain this arbitrary ethical boundary.
29:14Jenny Kleeman:You do need to be flexible when you're looking at these things. But the thing about Cathy is her association with He Jun Kuei does tarnish this somewhat. Because He Jun Kuei has tweeted at length about how inevitable it will be to do genetic engineering for intelligence, for enhancement, as opposed to just medicine. And if she is doing this, if her objective is really just to help the sickest, most vulnerable individuals on this planet, why did she have this close association with this man? And why isn't she prepared to completely disown everything that he did? And so I do feel like we are moving closer to a world where gene editing of embryos is going to happen.
30:01Jenny Kleeman:But it concerns me greatly that this American model of the way to make this happen is through genetic engineering startups rather than through proper scientific research. And I understand why there isn't this scientific research is because there's a moratorium on that research. But it would be really worrying if a consequence of that moratorium is you've got Sam Altman and Kathy Tai driving it.
30:25Cathy Tie:Yeah, I was going to say, Sam Altman, this discussion really reminds me of the discussion around AI right now. It's inevitable.
30:33Jenny Kleeman:It's exactly the same thing. It's exactly the same discourse of this is definitely going to happen. So we might as well have good people driving it or we might as well have me driving it because I know what I'm doing. I know. Do I want to? Is she a good person? Well, it's exactly the same thing with AI and China. We can't have any regulation on AI because otherwise China is going to beat us. We can't have any regulation on genetic engineering of embryos, otherwise China is going to get there first. And there is a sense that China is moving forward, even though it was the Chinese authorities that put He Jiankui in prison after he broke the rules.
31:08Jenny Kleeman:There is that argument. But there's a point in which we have to step back and say, just because we think other people might be doing it? Is this a reason for us to race to the bottom of doing it? And we should be able to have a mature conversation about this without saying, we've got to hurry up and do this first. Otherwise, you know, we're going to be left behind and this is inevitable, it's going to happen anyway. So we must make sure we're at the front of it.
31:34Cathy Tie:Fascinating and terrifying in equal measure. Jenny, thank you very much.
31:38Jenny Kleeman:Thank you so much.
31:41Cathy Tie:That was Jenny Kleeman. You can read her interview with Kathy at theguardian.com. And that is all for today. This episode was produced by Casey McClure and Tom Glasser and presented by me, Helen Pidd. Sound design was by Ross Burns and the executive producer was Eli Block. We'll be back in your feeds this afternoon with the latest.
32:03Jenny Kleeman:This is The Guardian.




